» Articles » PMID: 21483807

Ancestral Mutation in Telomerase Causes Defects in Repeat Addition Processivity and Manifests As Familial Pulmonary Fibrosis

Overview
Journal PLoS Genet
Specialty Genetics
Date 2011 Apr 13
PMID 21483807
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

The telomerase reverse transcriptase synthesizes new telomeres onto chromosome ends by copying from a short template within its integral RNA component. During telomere synthesis, telomerase adds multiple short DNA repeats successively, a property known as repeat addition processivity. However, the consequences of defects in processivity on telomere length maintenance are not fully known. Germline mutations in telomerase cause haploinsufficiency in syndromes of telomere shortening, which most commonly manifest in the age-related disease idiopathic pulmonary fibrosis. We identified two pulmonary fibrosis families that share two non-synonymous substitutions in the catalytic domain of the telomerase reverse transcriptase gene hTERT: V791I and V867M. The two variants fell on the same hTERT allele and were associated with telomere shortening. Genealogy suggested that the pedigrees shared a single ancestor from the nineteenth century, and genetic studies confirmed the two families had a common founder. Functional studies indicated that, although the double mutant did not dramatically affect first repeat addition, hTERT V791I-V867M showed severe defects in telomere repeat addition processivity in vitro. Our data identify an ancestral mutation in telomerase with a novel loss-of-function mechanism. They indicate that telomere repeat addition processivity is a critical determinant of telomere length and telomere-mediated disease.

Citing Articles

Viewpoint: Pre- and post-lung transplant considerations for patients with ultra-short telomere length.

Shah P, Armanios M Eur Respir J. 2025; 65(3).

PMID: 39884762 PMC: 11883148. DOI: 10.1183/13993003.01545-2024.


A persistent variant telomere sequence in a human pedigree.

Hinchie A, Sanford S, Loughridge K, Sutton R, Parikh A, Gil Silva A Nat Commun. 2024; 15(1):4681.

PMID: 38824190 PMC: 11144197. DOI: 10.1038/s41467-024-49072-9.


Pulmonary, Hepatic, and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Telomere Biology Disorders.

Pennington K, Simonetto D, Taner T, Mangaonkar A Curr Hematol Malig Rep. 2024; 19(6):293-299.

PMID: 38315384 DOI: 10.1007/s11899-024-00724-z.


2.7 Å cryo-EM structure of human telomerase H/ACA ribonucleoprotein.

Ghanim G, Sekne Z, Balch S, van Roon A, Nguyen T Nat Commun. 2024; 15(1):746.

PMID: 38272871 PMC: 10811338. DOI: 10.1038/s41467-024-45002-x.


Telomeres: Dysfunction, Maintenance, Aging and Cancer.

Liao P, Yan B, Wang C, Lei P Aging Dis. 2024; 15(6):2595-2631.

PMID: 38270117 PMC: 11567242. DOI: 10.14336/AD.2023.1128.


References
1.
Skoog L, Bjursell G . Nuclear and cytoplasmic pools of deoxyribonucleoside triphosphates in Chinese hamster ovary cells. J Biol Chem. 1974; 249(20):6434-8. View

2.
Goldman F, Bouarich R, Kulkarni S, Freeman S, Du H, Harrington L . The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc Natl Acad Sci U S A. 2005; 102(47):17119-24. PMC: 1287981. DOI: 10.1073/pnas.0505318102. View

3.
Greider C, Blackburn E . Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 1985; 43(2 Pt 1):405-13. DOI: 10.1016/0092-8674(85)90170-9. View

4.
Wang F, Podell E, Zaug A, Yang Y, Baciu P, Cech T . The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature. 2007; 445(7127):506-10. DOI: 10.1038/nature05454. View

5.
Chen J, Astle C, Harrison D . Development and aging of primitive hematopoietic stem cells in BALB/cBy mice. Exp Hematol. 1999; 27(5):928-35. DOI: 10.1016/s0301-472x(99)00018-1. View